Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Chuck Kennedy

Axios Executive Editor Mike Allen and Executive Vice President Evan Ryan explore the innovations and solutions needed to end cancer as we know it. They discussed with:

  • The Honorable Joseph R. Biden Jr., 47th Vice President of the United States, Co-Chair, Biden Cancer Initiative
  • Dr. Jill Biden, Co-Chair, Biden Cancer Initiative
  • Mr. Mark Alles, CEO, Celgene Corporation
  • Ms. Stefanie Joho, Cancer Survivor and Advocate
  • Dr. Elizabeth Jaffee, Dana and Albert "Cubby" Broccoli Professor of Oncology, Deputy Director, Kimmel Cancer Center at Johns Hopkins
  • Mr. Sean Parker, Founder and Chairman of the Parker Institute for Cancer Immunotherapy
Guests line up inside Philadelphia's National Constitution Center. Chuck Kennedy
Mike Allen explains that today's program will illuminate what the future of cancer care could look like. Chuck Kennedy
Vice President Biden says we're at an inflection point in cancer research because of science and technology, but now it's time to break down the barriers that prevent sharing data. Chuck Kennedy
Joho, a cancer survivor whose life was saved by a clinical trial, explains the role patients play in cancer research. "Patients are partners of science - the science won't progress without us."Chuck Kennedy
"We can change cancer forever if we can put together all of these modalities - chemotherapy, radiotherapy, immunotherapy," Alles tells Evan Ryan. Chuck Kennedy
Parker tells Mike: "When you see this gap between what's possible and what's actually being done, that gap is your opportunity for disruption." Chuck Kennedy
Over 175 guests joined us in learning about what cancer research and care could become. Chuck Kennedy

Go deeper

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities tied to Iranian-backed militia groups in Syria was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

2 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios